The Impact of Prostate Cancer Treatment on Patients’ Everyday Life
- Health at Bayer
Treatments & Therapies
- Chronic Kidney Disease
- Eye Conditions
- Healthy Aging
- Hormonal & Reproductive Health
Innovation & Technologies
- Patient Access Charter
- Leadership Perspective
- Strengthening Healthcare Access
- Empowering Women, Globally
- Fighting Neglected Tropical Diseases
- Moving Non-Communicable Diseases Care Forward
- Ensuring a Sustainable Product Supply
- Delivering Better Cancer Care
- News & Stories
- Clinical Trials Explorer
- Transparency Policy
- Treatments & Therapies
- Our Commitments
- Report a Side Effect
- Medical Counterfeits
For years, prostate cancer has carried a stigma of being an easy cancer: one that men live with and that doctors can simply “watch and wait”. But many people do not realize that prostate cancer is a complex disease. For some men, it can progress to advanced stages that require treatment and can have a significant impact on their daily lives.
Movember 2021: #LifeisMeantForLiving
During Movember, Bayer is sharing experiences from men living with different stages of prostate cancer to raise awareness and educate others who may be impacted by this disease.
At Bayer, we believe a patient’s #LifeIsMeantForLiving – meaning surviving and thriving. One way to achieve this is through appropriate treatment options.
Recent research among men with prostate cancer has shown that fatigue and other treatment side effects can negatively impact quality of life. This #Movember we want to highlight that reducing negative side effects should be a key consideration.
We have asked patients and caregivers from around the world to tell us what #LifeisMeantForLiving means to them.
Follow Bayer’s Twitter and Facebook channels this month for more information on prostate cancer.
About Prostate Cancer at Bayer
Bayer is committed to delivering science for a better life by advancing a portfolio of innovative treatments. The company has the passion and determination to develop new medicines that help improve and extend the lives of people living with cancer. Prostate cancer is the second most commonly diagnosed cancer in men, and a key area of focus for Bayer. The company’s franchise includes two products on the market (Nubeqa™ and Xofigo™) and several compounds in development, including a unique approach of advancing targeted alpha therapies. Bayer is focused on addressing the unique needs of prostate cancer patients, providing treatments that extend their lives throughout the different stages of the disease and allowing them to continue their everyday activities, so that they can live longer, better lives.